The FDA has cleared a multiplex polymerase chain reaction test designed to detect 11 clinically relevant gastrointestinal pathogens from a single stool sample.The Xpert GI Panel (Cepheid) can identify ...
COVID-19 patients show a 37% higher risk of developing new gastrointestinal disorders compared to COVID-19-negative individuals. The study analyzed data from over 1.1 million patients, with 56,745 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results